Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2003 AND VI 21 AND IP 6
Results: 7
1
2
Cost-benefit model comparing two alternative immunisation programmes against serogroup C meningococcal disease: for Quebec residents aged 2 months to 20 years.
- Published in:
- 2003
- By:
- Publication type:
- journal article
3
A pharmacy-based health promotion programme in hypertension: cost-benefit analysis.
- Published in:
- 2003
- By:
- Publication type:
- journal article
4
Outpatient Therapy for Febrile Neutropenia: Clinical and Economic Implications.
- Published in:
- PharmacoEconomics, 2003, v. 21, n. 6, p. 397, doi. 10.2165/00019053-200321060-00004
- By:
- Publication type:
- Article
5
Breast Cancer Management: Quality-of-Life and Cost Considerations.
- Published in:
- PharmacoEconomics, 2003, v. 21, n. 6, p. 383, doi. 10.2165/00019053-200321060-00003
- By:
- Publication type:
- Article
6
Health-Related Quality of Life and Regulatory Issues in the US and Canada: A Viewpoint by Barbara Blumenauer and Peter Tugwell.
- Published in:
- PharmacoEconomics, 2003, v. 21, n. 6, p. 379, doi. 10.2165/00019053-200321060-00002
- By:
- Publication type:
- Article
7
Health-related quality of life and regulatory issues in the US and Canada.
- Published in:
- 2003
- By:
- Publication type:
- journal article